Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Opinion in Urology|April 24, 2025
Prostate-specific membrane antigen positron-emission tomography for novel risk-stratification of biochemical recurrenceMadeleine J Karpinski, Claudia Kesch, Boris A Hadaschik, et al.
Seminars in Nuclear Medicine|December 26, 2025
The value of PSMA PET for risk stratification in prostate cancer: an update and future aspectsCaner Civan, Madeleine J Karpinski, Kambiz Rahbar, et al.
Clinical Genitourinary Cancer|January 1, 2025
Incidence and Survival of Patients With Prostate Cancer in North-Rhine Westphalia, GermanyMadeleine J Karpinski, Kevin Claassen, Lennart Möller, et al.
The Lancet. Oncology|August 1, 2024
Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective studyMadeleine J Karpinski, Johannes Hüsing, Kevin Claassen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2026
Salvage Radiotherapy Confers an Overall Survival Advantage in Biochemical Recurrence of Prostate Cancer: Evidence from the International PROMISE RegistryNika Guberina, Madeleine J Karpinski, Maja Guberina, et al.
The Lancet. Oncology|March 12, 2026
New prostate cancer risk groups by PSMA-PET (PPP3): an international, retrospective, registry-based cohort studyMadeleine J Karpinski, Caner Civan, Isabel Rauscher, et al.
Pageof 1